Expression by transgenesis of a constitutively active mutant form of the prolactin receptor induces premature abnormal development of the mouse mammary gland and lactation failure
- PMID: 14613905
- DOI: 10.1095/biolreprod.103.019448
Expression by transgenesis of a constitutively active mutant form of the prolactin receptor induces premature abnormal development of the mouse mammary gland and lactation failure
Abstract
Prolactin (PRL) initiates signal transduction by inducing homodimerization of PRL receptor (PRL-R). We have previously developed a mutant form of the PRL-R in which a part of the extracellular domain is deleted. This receptor constitutively activates protein gene transcription. We examined the oligomerization of the mutant PRL-R using two differently epitope-tagged receptors in a coimmunoprecipitation assay. It was shown that mutant receptor dimers were formed in a ligand-independent manner, which may explain the constitutive activity on milk protein gene expression. To study the biological activity of this mutant PRL-R on mammary gland development, we generated two lines of transgenic mice expressing the corresponding cDNA specifically in the mammary epithelial cells. For both transgenic lines, the mammary gland of 8-wk-old virgin mice was overdeveloped with numerous dilated ductal and alveolar structures, whereas only a limited duct network was present in wild-type animals at the same age. During pregnancy, the ducts and alveoli of transgenic mice were more developed than those of control animals. At parturition, the transgenic animals failed to lactate and nourish their offspring, and the involution of the mammary gland was strongly delayed. In conclusion, the expression of a constitutively active PRL-R by transgenesis induces a premature and abnormal mammary development and impairs terminal differentiation and milk production at the end of pregnancy.
Similar articles
-
Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.J Endocrinol. 2006 Aug;190(2):271-85. doi: 10.1677/joe.1.06829. J Endocrinol. 2006. PMID: 16899561
-
Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.Mol Cancer Res. 2002 Nov;1(1):32-47. Mol Cancer Res. 2002. PMID: 12496367
-
Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene.J Mol Endocrinol. 2006 Jun;36(3):435-48. doi: 10.1677/jme.1.01873. J Mol Endocrinol. 2006. PMID: 16720715
-
Effects of short day photoperiod on prolactin signaling in dry cows: a common mechanism among tissues and environments?J Anim Sci. 2008 Mar;86(13 Suppl):10-4. doi: 10.2527/jas.2007-0311. Epub 2007 Aug 8. J Anim Sci. 2008. PMID: 17686892 Review.
-
Insulin-like growth factor binding proteins initiate cell death and extracellular matrix remodeling in the mammary gland.Domest Anim Endocrinol. 2005 Aug;29(2):274-82. doi: 10.1016/j.domaniend.2005.02.021. Epub 2005 Apr 7. Domest Anim Endocrinol. 2005. PMID: 15998501 Review.
Cited by
-
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14533-8. doi: 10.1073/pnas.0800685105. Epub 2008 Sep 8. Proc Natl Acad Sci U S A. 2008. PMID: 18779591 Free PMC article.
-
Dynamic miRNA Landscape Links Mammary Gland Development to the Regulation of Milk Protein Expression in Mice.Animals (Basel). 2022 Mar 14;12(6):727. doi: 10.3390/ani12060727. Animals (Basel). 2022. PMID: 35327124 Free PMC article.
-
Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis.Mol Cell Biol. 2014 Apr;34(7):1363-77. doi: 10.1128/MCB.01220-13. Epub 2014 Jan 27. Mol Cell Biol. 2014. PMID: 24469394 Free PMC article.
-
Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.Mol Cell Biol. 2004 May;24(9):4038-48. doi: 10.1128/MCB.24.9.4038-4048.2004. Mol Cell Biol. 2004. PMID: 15082796 Free PMC article.
-
Rational design of competitive prolactin/growth hormone receptor antagonists.J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):105-17. doi: 10.1007/s10911-008-9066-8. Epub 2008 Jan 25. J Mammary Gland Biol Neoplasia. 2008. PMID: 18219565 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases